Hot Topics

3SBio Stock Soars (SSRX)

Shares of 3SBio (Nasdaq:SSRX) have taken a tremendous swing upward. The stock is trading at $14.57 as of 3:30 p.m. ET, 21.4% above Thursday's closing price of $12. Volume is at 204,335, 3.1 times the daily average of 66,000.

NEW YORK ( TheStreet) -- Shares of 3SBio (Nasdaq: SSRX) have taken a tremendous swing upward. The stock is trading at $14.57 as of 3:30 p.m. ET, 21.4% above Thursday's closing price of $12. Volume is at 204,335, 3.1 times the daily average of 66,000.

3SBio has a market cap of $241.7 million and is part of the health care sector and drugs industry. Shares are up 15% year to date as of the close of trading on Thursday.

3SBio Inc., a biotechnology company, engages in the research and development, manufacture, and distribution of pharmaceutical products in the People's Republic of China. The company has a P/E ratio of 18.1, below the average drugs industry P/E ratio of 20.7 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates 3SBio as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and a generally disappointing performance in the stock itself. You can view the full 3SBio Ratings Report.